Structures of influenza A proteins and insights into antiviral drug targets.
about
Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.Perspective of Use of Antiviral Peptides against Influenza VirusMisdelivery at the Nuclear Pore Complex-Stopping a Virus Dead in Its TracksThe polymerase of negative-stranded RNA virusesRecent progress in structure-based anti-influenza drug designInfluenza A Virus N5 Neuraminidase Has an Extended 150-CavityStructural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) PolymeraseStructural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccinesCrystallographic Fragment Screening and Structure-Based Optimization Yields a New Class of Influenza Endonuclease Inhibitors3-Hydroxyquinolin-2(1 H )-ones As Inhibitors of Influenza A EndonucleaseThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignPrevalence of epistasis in the evolution of influenza A surface proteinsMutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemicDimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functionsExploring the mechanism of zanamivir resistance in a neuraminidase mutant: a molecular dynamics studyPlasticity of 150-loop in influenza neuraminidase explored by Hamiltonian replica exchange molecular dynamics simulationsMutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonucleaseLocking the 150-cavity open: in silico design and verification of influenza neuraminidase inhibitorsAureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein HemagglutininGenomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technologyTwo years after pandemic influenza A/2009/H1N1: what have we learned?Progress of small molecular inhibitors in the development of anti-influenza virus agents.New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionH7N9: A killer in the making or a false alarm?From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Phenyl substituted 4-hydroxypyridazin-3(2H)-ones and 5-hydroxypyrimidin-4(3H)-ones: inhibitors of influenza A endonuclease.Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.Phylogenetic Analysis and Functional Characterization of the Influenza A H5N1 PB2 Gene.Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1.Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 virusesNationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009.Hallmarks of CD4 T cell immunity against influenzaComputer-based de novo designs of tripeptides as novel neuraminidase inhibitors.Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activationThe influenza virus NS1 protein as a therapeutic target.Fitness of neuraminidase inhibitor-resistant influenza A virusesProgress in structure-based drug design against influenza A virus.T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitroRecent progress and challenges in the discovery of new neuraminidase inhibitors.Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner.
P2860
Q24632337-ED5EE4A6-43C2-4218-A3E2-28B12535E70EQ26780434-51B32B19-F571-437D-8DC1-95B66488FD07Q26801484-3FB9432F-E677-4438-9602-5A3F5D970982Q26824373-01F5BC8D-AF6B-4FCA-BB02-E9A7BF9118E8Q26863710-F2E565C3-4CF0-4A1A-B792-1E869A6EDC4CQ27666275-C3876143-AC90-4CB0-BCAD-74D9CD6198FDQ27671365-7BCF8226-FBB2-4965-A019-C2F33E21155EQ27676658-BB825EF2-8E15-4FFE-840C-8F95B2CE5274Q27679805-47431EF6-6315-4B10-B303-68CDE203B3E7Q27684365-2717D234-E6AD-48D6-853F-55571D6F1FB2Q28071809-BE59153A-9068-4358-9A76-8EEA4136EAA7Q28477179-121D33D6-9982-4357-8E96-D4D548470B18Q28477952-4D374651-9DC2-48EA-93E9-07D152E31583Q28479054-0BF674FA-F6A1-4661-A5CB-D51F59543A3FQ28483631-6CC0B6C9-E5DC-44D7-8974-B5023F9EE9EDQ28486130-0DE24984-B2A0-4017-8253-65B2553FA0D8Q28534627-C9A49820-C2DA-4EB7-A885-370BB2F3FB2AQ28535754-04DFAA3B-D769-4F41-99F5-E73FB62AAE0AQ28550191-393E2611-2FE2-42A0-AEB8-B457CD2E23C8Q28748906-7CDB7E35-44A8-4ED7-BDC9-00C3FAB8B80AQ30224656-E909DD49-4750-48E9-BF0D-22213ABAC16FQ30234943-0FD09133-215B-486A-9958-477BAC62631DQ30355297-A5AF605E-6E47-4D41-BE7E-D85F1199D1F8Q30363225-3F62DD6F-A856-4E76-9E30-5890795EA4BBQ30363724-EE109035-1B43-4A48-98EC-32A6E19BDE2FQ30366846-9C9A1A63-6D1F-4CE4-914C-E2D6355F59B0Q30369353-362C5E8F-ED5E-4A05-9107-D876773E8C3DQ30374833-DAF44B79-F07C-47BD-9A10-D3010C83910DQ30392359-DD44707E-8B96-4B1B-973C-F7A30FB7912EQ30394447-AD328407-3B27-4321-99B6-0FEA53DB7243Q30398740-52EBE281-1EBE-4EF0-A1A7-0778B91B0F0DQ30400290-60CB440A-3745-4FD6-8C2B-DD3886330B78Q30403144-7AC87D7B-4EA3-496F-985F-3899667720F8Q30404141-42366D4B-FBA0-47A3-98BC-E4CBC32D679FQ30407133-80506105-A527-4149-94B2-3160322C2DF1Q30414559-1A075D43-C7C1-4CFC-A9AE-C997A644B456Q30417369-AAAEC8EF-1EE2-41F5-ACEB-4290CAC2006CQ30426020-BA30898E-F7F7-4201-BC4C-73F1889189F2Q30426630-04D1601A-3479-48EF-91C2-5E865BD7E3D8Q30429134-2C445099-1C78-455D-A4BD-C13B41B8C270
P2860
Structures of influenza A proteins and insights into antiviral drug targets.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structures of influenza A proteins and insights into antiviral drug targets.
@ast
Structures of influenza A proteins and insights into antiviral drug targets.
@en
type
label
Structures of influenza A proteins and insights into antiviral drug targets.
@ast
Structures of influenza A proteins and insights into antiviral drug targets.
@en
prefLabel
Structures of influenza A proteins and insights into antiviral drug targets.
@ast
Structures of influenza A proteins and insights into antiviral drug targets.
@en
P2093
P2860
P356
P1476
Structures of influenza A proteins and insights into antiviral drug targets
@en
P2093
Eddy Arnold
James M Aramini
Li-Chung Ma
Robert M Krug
P2860
P2888
P304
P356
10.1038/NSMB.1779
P50
P577
2010-04-11T00:00:00Z